<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02982473</url>
  </required_header>
  <id_info>
    <org_study_id>2016-612N-MA</org_study_id>
    <nct_id>NCT02982473</nct_id>
  </id_info>
  <brief_title>Registry of Malignant Arrhythmias and Sudden Cardiac Death - Influence of Diagnostics and Interventions</brief_title>
  <acronym>RACE-IT</acronym>
  <official_title>Registry of Malignant Arrhythmias and Sudden Cardiac Death - Influence of Diagnostics and Interventions</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitätsmedizin Mannheim</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universitätsmedizin Mannheim</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The &quot;Registry of Malignant Arrhythmias and Sudden Cardiac Death - Influence of Diagnostics
      and Interventions (RACE-IT)&quot; represents a mono-centric registry of patients being
      hospitalized suffering from malignant arrythmias (ventricular tachycardia or fibrillation)
      and sudden cardiac death (SCD).

      Detailed findings of patients' clinical outcome regarding mortality and co-morbidities
      related to the presence of invasive diagnostics or therapies including coronary angiography,
      percutaneous coronary intervention (PCI), electrophysiological testing (EP), catheter
      ablation and implanted cardiac devices (e.g. implantable cardioverter-defibrillators) will be
      documented. Patients will be included when being hospitalized from the year 2004 until today.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2016</start_date>
  <completion_date type="Anticipated">July 2017</completion_date>
  <primary_completion_date type="Anticipated">January 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of ventricular arrythmias (i.e. ventricular fibrillation, ventricular tachykardia, asystole, SCD)</measure>
    <time_frame>Through study completion, potentially up to 12 years, depending on patient inclusion/first event and patients lifetime</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incidence of coronary artery disease (CAD) and PCI in patients with VF/VT/SCD</measure>
    <time_frame>Through study completion, potentially up to 12 years, depending on patient inclusion/first event and patients lifetime</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of invasive electrophysiologic testing (EP) and catheter ablation</measure>
    <time_frame>Through study completion, potentially up to 12 years, depending on patient inclusion/first event and patients lifetime</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of treatment with cardiac devices (i.e. ICD, CCM, CRT-D)</measure>
    <time_frame>Through study completion, potentially up to 12 years, depending on patient inclusion/first event and patients lifetime</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidences of recurrent malignant tachycardias, all-cause mortality, arrhythmia-related death, re-PCI/ACVB, re-ablation, further therapy with cardiac devices</measure>
    <time_frame>Through study completion, potentially up to 12 years, depending on patient inclusion/first event and patients lifetime</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">3200</enrollment>
  <condition>Ventricular Tachycardia</condition>
  <condition>Ventricular Fibrillation</condition>
  <condition>Sudden Cardiac Death</condition>
  <condition>Coronary Angiography</condition>
  <condition>Electrophysiologic Testing (EP)</condition>
  <condition>Catheter Ablation</condition>
  <condition>Percutaneous Coronary Intervention (PCI)</condition>
  <condition>Internal Cardioverter Defibrillator (ICD)</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients being hospitalized with diagnoses of ventricular tachycardia, ventricular
        fibrillation and/or sudden cardiac death at the First Department of Medicine, University
        Medical Centre Mannheim, Germany.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Hospitalization due to:

          -  ventricular tachycardia

          -  ventricular fibrillation

          -  sudden cardiac death

        Exclusion Criteria:

          -  not diagnosed with one or more of the above
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ibrahim Akin, Prof. Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>First Deparment of Medicine, University Medical Centre Mannheim (UMM), Germany; Theodor-Kutzer-Ufer 1-3; 61867 Mannheim, Germany</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ibrahim Akin, Prof. Dr.</last_name>
    <phone>+49 621 383 5229</phone>
    <email>ibrahim.akin@umm.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Michael Behnes, Dr. med.</last_name>
    <phone>+49 621 383 6239</phone>
    <email>michael.behnes@umm.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>First Department of Medicine, University Medical Centre Mannheim</name>
      <address>
        <city>Mannheim</city>
        <zip>68167</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ibrahim Akin, MD, PhD</last_name>
      <email>ibrahim.akin@umm.de</email>
    </contact>
    <contact_backup>
      <last_name>Michael Behnes, MD</last_name>
      <email>michael.behnes@umm.de</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>November 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 29, 2016</study_first_submitted>
  <study_first_submitted_qc>November 30, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 5, 2016</study_first_posted>
  <last_update_submitted>November 30, 2016</last_update_submitted>
  <last_update_submitted_qc>November 30, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 5, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universitätsmedizin Mannheim</investigator_affiliation>
    <investigator_full_name>Michael Behnes</investigator_full_name>
    <investigator_title>Sub-PI</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Death</mesh_term>
    <mesh_term>Tachycardia</mesh_term>
    <mesh_term>Tachycardia, Ventricular</mesh_term>
    <mesh_term>Death, Sudden, Cardiac</mesh_term>
    <mesh_term>Ventricular Fibrillation</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

